Offer - Urjas Oil for just ₹ 1 X
Biceltis, a prescription drug, is manufactured in various forms such as Injection. It is primarily used for the treatment of Breast Cancer. Biceltis also has some secondary and off-label uses. These are listed below.
The optimal dosage of Biceltis is largely dependent on the individual's body weight, medical history, gender and age. The condition it has been prescribed for, and the route of administration also determine the right dosage. This information has been provided in detail in the dosage section.
Common side effects of Biceltis include Insomnia, Infection, Upper respiratory tract infection. Some other side effects of Biceltis have been listed ahead. Usually, these side effects of Biceltis go away soon, and do not persist beyond the duration of the treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
In addition, Biceltis's effect is Severe during pregnancy and Severe for lactating mothers. It is important to know if Biceltis has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Biceltis related warnings section.
Biceltis is not recommended if you suffer from certain medical conditions as it can have adverse effects. Asthma, COPD (Chronic Obstructive Pulmonary Disease), Pneumonitis are examples of such conditions. Other conditions have been mentioned below in the Biceltis contraindications section.
Besides this, Biceltis may also have severe interaction with some medicines. See below for a complete list.
You should also be aware that Biceltis is not safe while driving, and is not addiction.
Biceltis is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult(Female) |
|
Geriatric |
|
Adult |
|
Is the use of Biceltis safe for pregnant women?
Biceltis can cause severe side effects if taken during pregnancy, so, pregnant women should talk to their doctor before taking it.
Is the use of Biceltis safe during breastfeeding?
Women who are breastfeeding may experience severe harmful effects after taking Biceltis. It should only be taken after medical advice.
What is the effect of Biceltis on the Kidneys?
Biceltis does not damage the kidneys.
What is the effect of Biceltis on the Liver?
There are no any side effects of Biceltis on the liver.
What is the effect of Biceltis on the Heart?
The heart can be affected by Biceltis. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart the medicine only after medical advice.
Biceltis should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Biceltis unless your doctor advises you to do so -
Is this Biceltis habit forming or addictive?
Biceltis is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Biceltis can make you feel drowsy.
Is it safe?
Yes, but consume Biceltis only on doctor's advice.
Is it able to treat mental disorders?
No, the use of Biceltis in mental disorders is not effective.
Interaction between Food and Biceltis
You can take Biceltis with food.
Interaction between Alcohol and Biceltis
It is difficult to say anything about the effect of Biceltis and alcohol. No research has been done on this yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Herceptin® (trastuzumab)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 114-116